Robert Crotty Nabriva Therapeutics PLC (NBRV) insider trading activity

Robert Crotty is Gen Counsel & Corp Secretary of Nabriva Therapeutics plc. Currently has a direct ownership of 41,194 shares of NBRV, which is worth approximately $16,477. The most recent transaction as insider was on Aug 31, 2021, when has been sold 37 shares (Ordinary Shares) at a price of $1.06 per share, resulting in proceeds of $39. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 41.2K

0% 3M change

0% 12M change

Total Value Held $16,477

Robert Crotty Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 31 2021	SELL Payment of exercise price or tax liability	$39 $1.06 p/Share	37 Reduced 0.09%	41,194 Ordinary Shares
Aug 06 2021	SELL Payment of exercise price or tax liability	$87 $1.17 p/Share	74 Reduced 0.18%	41,231 Ordinary Shares
Jul 31 2021	SELL Payment of exercise price or tax liability	$41 $1.1 p/Share	37 Reduced 0.09%	41,305 Ordinary Shares
Jul 06 2021	SELL Payment of exercise price or tax liability	$94 $1.27 p/Share	74 Reduced 0.18%	41,342 Ordinary Shares
Jun 30 2021	SELL Payment of exercise price or tax liability	$50 $1.35 p/Share	37 Reduced 0.09%	41,416 Ordinary Shares
Jun 06 2021	SELL Payment of exercise price or tax liability	$98 $1.34 p/Share	73 Reduced 0.18%	41,453 Ordinary Shares
May 31 2021	SELL Payment of exercise price or tax liability	$51 $1.38 p/Share	37 Reduced 0.09%	41,526 Ordinary Shares
May 06 2021	SELL Payment of exercise price or tax liability	$110 $1.49 p/Share	74 Reduced 0.18%	41,563 Ordinary Shares
Apr 30 2021	SELL Payment of exercise price or tax liability	$66 $1.78 p/Share	37 Reduced 0.09%	41,637 Ordinary Shares
Apr 06 2021	SELL Payment of exercise price or tax liability	$128 $1.73 p/Share	74 Reduced 0.18%	41,674 Ordinary Shares
Mar 31 2021	SELL Payment of exercise price or tax liability	$61 $1.66 p/Share	37 Reduced 0.09%	42,689 Ordinary Shares
Mar 06 2021	SELL Payment of exercise price or tax liability	$127 $1.79 p/Share	71 Reduced 0.17%	41,748 Ordinary Shares
Feb 28 2021	SELL Payment of exercise price or tax liability	$91 $2.39 p/Share	38 Reduced 0.09%	42,726 Ordinary Shares
Feb 06 2021	SELL Payment of exercise price or tax liability	$2,523 $2.9 p/Share	870 Reduced 2.04%	41,819 Ordinary Shares
Jan 31 2021	SELL Payment of exercise price or tax liability	$113 $2.62 p/Share	43 Reduced 0.1%	42,764 Ordinary Shares
Jan 29 2021	BUY Grant, award, or other acquisition	-	22,500 Added 34.45%	42,807 Ordinary Shares
Dec 31 2020	SELL Payment of exercise price or tax liability	$90 $2.42 p/Share	37 Reduced 0.18%	20,307 Ordinary Shares
Nov 30 2020	SELL Payment of exercise price or tax liability	$158 $0.43 p/Share	368 Reduced 0.18%	203,444 Ordinary Shares
Oct 31 2020	SELL Payment of exercise price or tax liability	$183 $0.5 p/Share	366 Reduced 0.18%	203,812 Ordinary Shares
Sep 30 2020	SELL Payment of exercise price or tax liability	$194 $0.53 p/Share	366 Reduced 0.18%	204,178 Ordinary Shares

Robert Crotty

Gen Counsel & Corp Secretary

King Of Prussia, PA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NBRV shares.

Notify only if

Value

Insider Trading

Get notified when an Nabriva Therapeutics PLC insider buys or sells NBRV shares.

Notify only if

Operation

Value

Type

News

Receive news related to Nabriva Therapeutics plc

Track Activities on NBRV

Account